Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Blanke

Showing results (81-90 of 190) with videos related to

Pageof 19
Sort By:
Clinical Colorectal Cancer|December 17, 2005
Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinomaAlan P Venook, Charles D Blanke, Donna Niedzwiecki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 19, 2011
Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancerS Iqbal, B Goldman, C M Fenoglio-Preiser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinomaC D Blanke, D G Haller, A B Benson, et al.
Clinical Colorectal Cancer|June 8, 2007
Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinomaAlan P Venook, Charles D Blanke, Donna Niedzwiecki, et al.
Cancer|April 13, 2000
Activity of multitargeted antifolate (pemetrexed disodium, LY231514) in patients with advanced colorectal carcinoma: results from a phase II studyW John, J Picus, C D Blanke, et al.
Cancer|September 24, 2020
What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine reportMonica M Bertagnolli, Charles D Blanke, Walter J Curran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2016
American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer PreventionHoward H Bailey, Linus T Chuang, Nefertiti C duPont, et al.
Journal of Oncology Practice|January 11, 2019
Let's Talk About Those Herbs You Are Taking: Ethical Considerations for Communication With Patients With Cancer About Complementary and Alternative MedicineLaura Tenner, Fay J Hlubocky, Charles D Blanke, et al.
Current Oncology (Toronto, Ont.)|July 17, 2020
Tyrosine kinase inhibitors significantly improved survival outcomes in patients with metastatic gastrointestinal stromal tumour: a multi-institutional cohort studyA Deruchie Tan, K Willemsma, A MacNeill, et al.
Investigational New Drugs|April 9, 2001
A phase I study of vitamin E, 5-fluorouracil and leucovorin for advanced malignanciesC D Blanke, M Stipanov, J Morrow, et al.
Pageof 19

Showing results (81-90 of 190) with videos related to

Sort By:
Pageof 19
Clinical Colorectal Cancer|December 17, 2005
Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinomaAlan P Venook, Charles D Blanke, Donna Niedzwiecki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 19, 2011
Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancerS Iqbal, B Goldman, C M Fenoglio-Preiser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinomaC D Blanke, D G Haller, A B Benson, et al.
Clinical Colorectal Cancer|June 8, 2007
Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinomaAlan P Venook, Charles D Blanke, Donna Niedzwiecki, et al.
Cancer|April 13, 2000
Activity of multitargeted antifolate (pemetrexed disodium, LY231514) in patients with advanced colorectal carcinoma: results from a phase II studyW John, J Picus, C D Blanke, et al.
Cancer|September 24, 2020
What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine reportMonica M Bertagnolli, Charles D Blanke, Walter J Curran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2016
American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer PreventionHoward H Bailey, Linus T Chuang, Nefertiti C duPont, et al.
Journal of Oncology Practice|January 11, 2019
Let's Talk About Those Herbs You Are Taking: Ethical Considerations for Communication With Patients With Cancer About Complementary and Alternative MedicineLaura Tenner, Fay J Hlubocky, Charles D Blanke, et al.
Current Oncology (Toronto, Ont.)|July 17, 2020
Tyrosine kinase inhibitors significantly improved survival outcomes in patients with metastatic gastrointestinal stromal tumour: a multi-institutional cohort studyA Deruchie Tan, K Willemsma, A MacNeill, et al.
Investigational New Drugs|April 9, 2001
A phase I study of vitamin E, 5-fluorouracil and leucovorin for advanced malignanciesC D Blanke, M Stipanov, J Morrow, et al.
Pageof 19